A citation-based method for searching scientific literature

Laura Spugnesi, Cristina Balia, Anita Collavoli, Elisabetta Falaschi, Valentina Quercioli, Maria Adelaide Caligo, Alvaro Galli. Mutagenesis 2013
Times Cited: 14







List of co-cited articles
143 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Apoptosis in yeast: triggers, pathways, subroutines.
D Carmona-Gutierrez, T Eisenberg, S Büttner, C Meisinger, G Kroemer, F Madeo. Cell Death Differ 2010
330
14

Achievements and perspectives in yeast acetic acid-induced programmed cell death pathways.
Nicoletta Guaragnella, Lucia Antonacci, Salvatore Passarella, Ersilia Marra, Sergio Giannattasio. Biochem Soc Trans 2011
34
14

BRCA1 and its toolbox for the maintenance of genome integrity.
Michael S Y Huen, Shirley M H Sy, Junjie Chen. Nat Rev Mol Cell Biol 2010
340
14

The role of mitochondria in yeast programmed cell death.
Nicoletta Guaragnella, Maša Zdralević, Lucia Antonacci, Salvatore Passarella, Ersilia Marra, Sergio Giannattasio. Front Oncol 2012
45
14

Catalase T and Cu,Zn-superoxide dismutase in the acetic acid-induced programmed cell death in Saccharomyces cerevisiae.
Nicoletta Guaragnella, Lucia Antonacci, Sergio Giannattasio, Ersilia Marra, Salvatore Passarella. FEBS Lett 2008
37
14

Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2.
Loredana Moro, Arnaldo A Arbini, Ersilia Marra, Margherita Greco. Int J Oncol 2007
30
14

Nobel Lecture. Yeast and cancer.
Leland H Hartwell. Biosci Rep 2002
73
14

Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation.
Loredana Moro, Arnaldo A Arbini, Ersilia Marra, Margherita Greco. J Biol Chem 2005
23
14

DSS1 is required for the stability of BRCA2.
J Li, C Zou, Y Bai, D E Wazer, V Band, Q Gao. Oncogene 2006
87
14

Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2.
L Moro, A A Arbini, J L Yao, P A di Sant'Agnese, E Marra, M Greco. Cell Death Differ 2009
78
14



Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing.
J S Humphrey, A Salim, M R Erdos, F S Collins, L C Brody, R D Klausner. Proc Natl Acad Sci U S A 1997
95
14

The breast cancer information core: database design, structure, and scope.
C Szabo, A Masiello, J F Ryan, L C Brody. Hum Mutat 2000
135
14


Yeast as a model for medical and medicinal research.
Willem H Mager, Joris Winderickx. Trends Pharmacol Sci 2005
134
14

Cytochrome c is released from coupled mitochondria of yeast en route to acetic acid-induced programmed cell death and can work as an electron donor and a ROS scavenger.
Sergio Giannattasio, Anna Atlante, Lucia Antonacci, Nicoletta Guaragnella, Paolo Lattanzio, Salvatore Passarella, Ersilia Marra. FEBS Lett 2008
46
14

Homologous recombination and its regulation.
Lumir Krejci, Veronika Altmannova, Mario Spirek, Xiaolan Zhao. Nucleic Acids Res 2012
366
14

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
14

Functional assays for BRCA1 and BRCA2.
Marcelo A Carvalho, Fergus J Couch, Alvaro N A Monteiro. Int J Biochem Cell Biol 2007
41
14

Assessment of human Nter and Cter BRCA1 mutations using growth and localization assays in yeast.
Gaël A Millot, Adeline Berger, Vincent Lejour, Jean-Baptiste Boulé, Claude Bobo, Christophe Cullin, Judith Lopes, Dominique Stoppa-Lyonnet, Alain Nicolas. Hum Mutat 2011
13
15



Two classes of BRC repeats in BRCA2 promote RAD51 nucleoprotein filament function by distinct mechanisms.
Aura Carreira, Stephen C Kowalczykowski. Proc Natl Acad Sci U S A 2011
94
14

Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members.
Mads Thomassen, Ana Blanco, Marco Montagna, Thomas V O Hansen, Inge S Pedersen, Sara Gutiérrez-Enríquez, Mireia Menéndez, Laura Fachal, Marta Santamariña, Ane Y Steffensen,[...]. Breast Cancer Res Treat 2012
47
14

A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay.
Kajal Biswas, Ranabir Das, Blanche P Alter, Sergey G Kuznetsov, Stacey Stauffer, Susan L North, Sandra Burkett, Lawrence C Brody, Stefan Meyer, R Andrew Byrd,[...]. Blood 2011
35
14

BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.
Rinske Drost, Peter Bouwman, Sven Rottenberg, Ute Boon, Eva Schut, Sjoerd Klarenbeek, Christiaan Klijn, Ingrid van der Heijden, Hanneke van der Gulden, Ellen Wientjens,[...]. Cancer Cell 2011
158
14

Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions.
Maria Kraakman-van der Zwet, Wilhelmina J I Overkamp, Rebecca E E van Lange, Jeroen Essers, Annemarie van Duijn-Goedhart, Ingrid Wiggers, Srividya Swaminathan, Paul P W van Buul, Abdellatif Errami, Raoul T L Tan,[...]. Mol Cell Biol 2002
205
14

Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.
David E Goldgar, Douglas F Easton, Amie M Deffenbaugh, Alvaro N A Monteiro, Sean V Tavtigian, Fergus J Couch. Am J Hum Genet 2004
275
14

Involvement of Brca2 in DNA repair.
K J Patel, V P Yu, H Lee, A Corcoran, F C Thistlethwaite, M J Evans, W H Colledge, L S Friedman, B A Ponder, A R Venkitaraman. Mol Cell 1998
492
14

Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification.
A Tutt, A Gabriel, D Bertwistle, F Connor, H Paterson, J Peacock, G Ross, A Ashworth. Curr Biol 1999
243
14

A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1.
Edwin S Iversen, Fergus J Couch, David E Goldgar, Sean V Tavtigian, Alvaro N A Monteiro. Cancer Epidemiol Biomarkers Prev 2011
38
14

BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts.
Asta Björk Jonsdottir, Maaike P G Vreeswijk, Ron Wolterbeek, Peter Devilee, Hans J Tanke, Jorunn E Eyfjörd, Karoly Szuhai. Cell Oncol 2009
17
14


EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.
Luke Hughes-Davies, David Huntsman, Margarida Ruas, Francois Fuks, Jacqueline Bye, Suet-Feung Chin, Jonathon Milner, Lindsay A Brown, Forrest Hsu, Blake Gilks,[...]. Cell 2003
313
14

Unraveling the mechanism of BRCA2 in homologous recombination.
William K Holloman. Nat Struct Mol Biol 2011
117
14

A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization.
Anand D Jeyasekharan, Yang Liu, Hiroyoshi Hattori, Venkat Pisupati, Asta Bjork Jonsdottir, Eeson Rajendra, Miyoung Lee, Elayanambi Sundaramoorthy, Simon Schlachter, Clemens F Kaminski,[...]. Nat Struct Mol Biol 2013
61
14

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.
Stephen M Edwards, Zsofia Kote-Jarai, Julia Meitz, Rifat Hamoudi, Questa Hope, Peter Osin, Rachel Jackson, Christine Southgate, Rashmi Singh, Alison Falconer,[...]. Am J Hum Genet 2003
251
14


A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history.
Encarna B Gómez García, Jan C Oosterwijk, Maarten Timmermans, Christi J van Asperen, Frans B L Hogervorst, Nicoline Hoogerbrugge, Rogier Oldenburg, Senno Verhoef, Charlotte J Dommering, Margreet G E M Ausems,[...]. Breast Cancer Res 2009
41
14

Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations.
B H Spain, C J Larson, L S Shihabuddin, F H Gage, I M Verma. Proc Natl Acad Sci U S A 1999
108
14


PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2.
Fan Zhang, Qiang Fan, Keqin Ren, Paul R Andreassen. Mol Cancer Res 2009
186
14

A syngeneic variance library for functional annotation of human variation: application to BRCA2.
Tomas Hucl, Carlo Rago, Eike Gallmeier, Jonathan R Brody, Myriam Gorospe, Scott E Kern. Cancer Res 2008
53
14

A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression.
L Y Marmorstein, A V Kinev, G K Chan, D A Bochar, H Beniya, J A Epstein, T J Yen, R Shiekhattar. Cell 2001
110
14

Transcriptional activation functions in BRCA2.
J Milner, B Ponder, L Hughes-Davies, M Seltmann, T Kouzarides. Nature 1997
177
14

A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example.
Leila Mohammadi, Maaike P Vreeswijk, Rogier Oldenburg, Ans van den Ouweland, Jan C Oosterwijk, Annemarie H van der Hout, Nicoline Hoogerbrugge, Marjolijn Ligtenberg, Margreet G Ausems, Rob B van der Luijt,[...]. BMC Cancer 2009
44
14

Nuclear localization signals of the BRCA2 protein.
K Yano, K Morotomi, H Saito, M Kato, F Matsuo, Y Miki. Biochem Biophys Res Commun 2000
43
14

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey,[...]. Br J Cancer 2008
302
14

BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity.
Reena Shakya, Latarsha J Reid, Colleen R Reczek, Francesca Cole, Dieter Egli, Chyuan-Sheng Lin, Dirk G deRooij, Steffen Hirsch, Kandasamy Ravi, James B Hicks,[...]. Science 2011
162
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.